Science Explorer Back to mapMap
Discussion
Researcher · AlgiPharma (Norway) · Norway

Philip D. Rye

Philip D. Rye publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, on topics such as Glycosylation and Glycoproteins Research, Cystic Fibrosis Research Advances and Monoclonal and Polyclonal Antibodies Research.

ORCID 0000-0001-7762-3300 OpenAlex
World rank
#1,838,642
of 7,710,434 ranked researchers
Rank in Norway
#11,584
of 33,005
Works
85
Citations
2.1k
Citations per work
25.0
h-index
25
i10-index 44Top 22% in Molecular Biology
Philip D. Rye

What does Philip D. Rye research?

Philip D. Rye's work is mostly in Biochemistry, Genetics and Molecular Biology (22%), Medicine (22%), Chemistry (5%).

Everything else: 40 works · 47.0% of their workLife Sciences: 23 works · 26.7% of their workBiochemistry, Genetics and Molecular Biology: 19 works · 22.5% of their workMolecular Biology: 19 works · 22.5% of their workImmunology and Microbiology: 4 works · 4.2% of their workImmunology: 4 works · 4.2% of their workHealth Sciences: 18 works · 21.7% of their workMedicine: 18 works · 21.7% of their workPulmonary and Respiratory Medicine: 10 works · 12.1% of their workRadiology, Nuclear Medicine and Imaging: 5 works · 5.8% of their workOncology: 3 works · 3.8% of their workPhysical Sciences: 4 works · 4.6% of their workChemistry: 4 works · 4.6% of their workOrganic Chemistry: 4 works · 4.6% of their workTHEIR WORKPhilip D. Rye85works
Life Sciences27%Physical Sciences5%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else4047.0%
    1. Biochemistry, Genetics and Molecular Biology1922.5%
    2. Immunology and Microbiology44.2%
    1. Medicine1821.7%
    1. Chemistry44.6%
  1. 1Molecular Biology22% of their works
  2. 2Pulmonary and Respiratory Medicine12% of their works
  3. 3Radiology, Nuclear Medicine and Imaging6% of their works
  4. 4Organic Chemistry5% of their works
  5. 5Immunology4% of their works
  6. 6Oncology4% of their works

Research topics

Which keywords describe Philip D. Rye's research?

The keywords of their largest research topics: Glycosylation, Microbiota, Cancer, Glycans, Nanoparticles, CFTR, Cystic Fibrosis and Fc Receptors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Glycosylation342 topics
  2. Microbiota212 topics
  3. Cancer201 topic
  4. Glycans201 topic
  5. Nanoparticles172 topics
  6. CFTR151 topic
  7. Cystic Fibrosis151 topic
  8. Fc Receptors141 topic
  9. Therapeutic Antibodies141 topic
  10. Glycosidase Inhibitors101 topic
  11. Oligosaccharide Synthesis101 topic
  12. Inhaler Devices91 topic
  13. Pulmonary Drug Delivery91 topic
  14. Bacteria81 topic
  15. Biofilms81 topic
  16. Chitosan81 topic
  17. Mucosal81 topic
  18. Prebiotics61 topic
  19. Probiotics61 topic

Where does Philip D. Rye work?

Philip D. Rye's main affiliation in the publication record is AlgiPharma (Norway), Norway.

How many publications and citations does Philip D. Rye have?

OpenAlex counts 85 works and 2,129 citations for Philip D. Rye, an h-index of 25, ranking #1,838,642 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Philip D. Rye. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.